Regulatory Immunotherapy in Bone Marrow Transplantation
Joint Authors
Morales-Tirado, Vanessa
Luszczek, Wioleta
van der Merwe, Marié
Pillai, Asha
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-15, 15 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-01-02
Country of Publication
Egypt
No. of Pages
15
Main Subjects
Medicine
Information Technology and Computer Science
Abstract EN
Every year individuals receive hematopoietic stem cell transplantation (HSCT) to eradicate malignant and nonmalignant disease.
The immunobiology of allotransplantation is an area of ongoing discovery, from the recipient's conditioning treatment prior to the transplant to the donor cell populations responsible for engraftment, graft-versus-host disease, and graft-versus-tumor effect.
In this review, we focus on donor-type immunoregulatory T cells, namely, natural killer T cells (NKT) and regulatory T cells (Treg), and their current and potential roles in tolerance induction after allogeneic HSCT.
American Psychological Association (APA)
Morales-Tirado, Vanessa& Luszczek, Wioleta& van der Merwe, Marié& Pillai, Asha. 2012. Regulatory Immunotherapy in Bone Marrow Transplantation. The Scientific World Journal،Vol. 2011, no. 2011, pp.1-15.
https://search.emarefa.net/detail/BIM-991385
Modern Language Association (MLA)
Morales-Tirado, Vanessa…[et al.]. Regulatory Immunotherapy in Bone Marrow Transplantation. The Scientific World Journal No. 2011 (2011), pp.1-15.
https://search.emarefa.net/detail/BIM-991385
American Medical Association (AMA)
Morales-Tirado, Vanessa& Luszczek, Wioleta& van der Merwe, Marié& Pillai, Asha. Regulatory Immunotherapy in Bone Marrow Transplantation. The Scientific World Journal. 2012. Vol. 2011, no. 2011, pp.1-15.
https://search.emarefa.net/detail/BIM-991385
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-991385
